Skip to content

Effect of Specific ACL Injury Prevention Training in Female Handball Players

Effect of Specific ACL Injury Prevention Training in Female Handball Players

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05955599
Enrollment
80
Registered
2023-07-21
Start date
2022-01-01
Completion date
2025-12-31
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL Injury Prevention

Keywords

ACL Injuries, Age-related, Neuromuscular, Motor-Learning

Brief summary

The anterior Cruciate Ligament (ACL) injuries rates in female handball are high, particularly among adolescents. Therefore, the primary purpose of this randomized control trial is to explore the effects of an 8-week ACL injury prevention program on muscle activation of the medial hamstring muscles during sidecutting in female handball players. Secondary aims are to evaluate if training effects are age-related (pre-adolescent: 11-13 year old vs. adults: ≥18 years old). The age-related comparisons Include: 1. Medial hamstring muscles activation during sidecutting; 2. Well-known biomechanical ACL injury-risk factors during high risk movements, such as cutting and landing tasks; 3. Cortical and muscular activity and functional connectivity patterns during controlled knee movements; 4. Visuomotor skill learning during a simple task involving the hamstring muscles.

Interventions

OTHERACL Injury Prevention Training

Supervised ACL injury prevention training twice a week (2 x 15 minutes) over an 8-week period.

OTHERControl - Shoulder Injury Prevention Training

Supervised shoulder injury prevention training twice a week (2 x 15 minutes) over an 8-week period.

Sponsors

University College Copenhagen
CollaboratorOTHER
University of Copenhagen
CollaboratorOTHER
Team Denmark
CollaboratorOTHER
Copenhagen University Hospital, Hvidovre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
11 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Female handball players playing in youth teams from the age group under 13 (11-13 years old) and adult (≥18 - 40 years old) females playing for elite u19 or senior teams in Denmark * Have minimum 1 year of experience from playing handball * Mental and physical skills to complete the electrophysiological and biomechanical tests

Exclusion criteria

* Girls/women outside the age groups listed above * Prior surgeries to the lower limbs (e.g. ACL-reconstructions, meniscus lesions) * Current intake of medications that include antidepressants, anxiolytics, anticonvulsants, antipsychotics, antiparkinson, hypnotics, stimulants, and/or antihistamines * Neurological and/or psychiatric diagnoses * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Neuromuscular adaptations during sidecuttingChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Semitendinosus muscle pre-activity (sEMG) duirng handball specific sidecutting. Outcome measure is expressed in %MVC.during sidecutting.

Secondary

MeasureTime frameDescription
Changes in isometric strengthChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Peak isometric hamstring and hip external rotation strength, respectively. Outcome measure is expressed in force (Newtons).
Changes in 3D hip and knee joint anglesChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Hip and knee joint kinematic for sidecutting and single-leg landings. This include joint kinetics at initial contact and local maximum and minimums. Outcome is expressed in three-dimensional joint angles (degrees)
Changes in 3D hip and knee joint momentsChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Hip and knee joint kinetics for sidecutting and single-leg landings. Outcome is expressed in three-dimensional joint moments (M)
Changes in hamstring and quadriceps pre-activationChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Hamstring (biceps femoris) and quadriceps (vastus lateralis and medialis) pre-activation (sEMG) during sidecutting and single-leg landings. Outcome measure is expressed in %MVC.
Changes in shoulder sensorimoter stabilityChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Shoulder sensorimoter stability measured as CoP length (mm) from force platform data.
Changes in Shoulder Rotator Cuff StrengthChange from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Peak isometric internal and external rotator cuff strength. Outcome measure is expressed in force (Newtons).
Visuomotor Skill LearningChange from Baseline to Baseline +1 Day, Change from Baseline to Training Completion at 8 weeks. And retention 8-weeks after the prevention program was completed.Age-related differences in motor performance, skill acquisition and retention during and following visuomotor skill practice. Specific outcomes measure will be time on target (seconds per target).

Other

MeasureTime frameDescription
Injury monitoringWeekly for 16 weeks (from the start of the intervention to the end of the 8-week retention period)Type and number of injuries will be collected on a weekly basis using an electronical study-specific questionary. If injured, player's will be asked to complete a detailed questionary about the injury.
Training and match exposureWeekly for 16 weeks (from the start of the intervention to the end of the 8-week retention period)Number of training and match hours will be collected on a weekly basis using an electronical study-specific questionary

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026